VentureMed

VentureMed develops endovascular medical devices aimed at addressing unmet needs in the treatment of peripheral artery disease (PAD). The company’s devices create controlled, arbitrary-length micro-incisions in complex lesions of various morphologies, safely and predictably modifying plaque and stenosis while providing acute lumen gain, improving vascular compliance, and delivering consistently positive clinical vessel reconstruction outcomes in PAD. This enables healthcare providers to simplify, expedite, and make cost-effective vascular preparation.